Although mice with the stiff skin syndrome mutation, a genetic mouse model of SSc, show the presence of increased proinflammatory cells, including plasmacytoid dendritic cells, T-helper cells, and plasma cells in the skin, TGF-β-neutralizing antibody inhibited the inflammation and reversed the established skin fibrosis [31]. This evidence concerns the gene TGFB1 and stiff skin syndrome.